Your browser doesn't support javascript.
loading
Therapeutic Experience of Saxagliptin as First Add-on after Metformin in Indian Type 2 Diabetes Patients: A Non-interventional, Prospective, Observational Study (ONTARGET-INDIA).
Kalra, Sanjay; Bajaj, Sarita; Unnikrishnan, A G; Baruah, Manash P; Sahay, Rakesh; Hardik, V; Kumar, Amit.
Affiliation
  • Kalra S; Department of Endocrinology, Bharti Research Institute of Diabetes and Endocrinology, Karnal, Haryana, India.
  • Bajaj S; Department of Medicine, Moti Lal Nehru Medical College, Allahabad, Uttar Pradesh, India.
  • Unnikrishnan AG; Department of Clinical Diabetology and Endocrinology, Chellaram Diabetes Institute, Pune, Maharashtra, India.
  • Baruah MP; Department of Endocrinology, Excel Center, Maya Ville, Barthakur Mill Road, Ulubari, Guwahati, Assam, India.
  • Sahay R; Department of Endocrinology, Osmania General Hospital, Hyderabad, Telangana, India.
  • Hardik V; Department of Medical Affairs, AstraZeneca Pharma India Ltd, Bengaluru, Karnataka, India.
  • Kumar A; Department of Medical Affairs, AstraZeneca Pharma India Ltd, Bengaluru, Karnataka, India.
Indian J Endocrinol Metab ; 23(3): 312-317, 2019.
Article in En | MEDLINE | ID: mdl-31641633
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Observational_studies / Risk_factors_studies Aspects: Patient_preference Language: En Journal: Indian J Endocrinol Metab Year: 2019 Document type: Article Affiliation country: India Country of publication: India
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Observational_studies / Risk_factors_studies Aspects: Patient_preference Language: En Journal: Indian J Endocrinol Metab Year: 2019 Document type: Article Affiliation country: India Country of publication: India